UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9639, pp. 657 - 668
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Medical sciences | Tumors of the nervous system. Phacomatoses | Electroencephalography | Tuberous Sclerosis - diagnosis | Tuberous Sclerosis - complications | Humans | Tuberous Sclerosis - physiopathology | Tumor Suppressor Proteins - genetics | Early intervention | Photodynamic therapy | Medical imaging | Mortality | Kinases | Gene expression | Proteins | Surveillance | Genetics | Mutation | Kidney diseases | Methods | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 381, Issue 9869, pp. 817 - 824
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Angiomyolipoma - complications | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Prospective Studies | Double-Blind Method | Tuberous Sclerosis - complications | Humans | Male | Antineoplastic Agents - therapeutic use | Angiomyolipoma - drug therapy | Lymphangioleiomyomatosis - complications | Adult | Female | Everolimus | Research | Drug therapy | Patient outcomes | Tumors | Clinical trials | Tuberous sclerosis | Angiogenesis inhibitors | Pharmaceutical industry | Autism | Substance abuse treatment | Drug dosages | Collagen | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 381, Issue 9861, pp. 125 - 132
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Double-Blind Method | Tuberous Sclerosis - complications | Humans | Child, Preschool | Infant | Male | Treatment Outcome | Fever - chemically induced | Oral Ulcer - chemically induced | Seizures - chemically induced | Astrocytoma - complications | Young Adult | Stomatitis - chemically induced | Adolescent | Astrocytoma - drug therapy | Adult | Female | Child | Everolimus | Sirolimus - adverse effects | Tuberous sclerosis | Complications and side effects | Research | Drug therapy | Astrocytoma | Risk factors | Kinases | Medical treatment | Epilepsy | Colorectal cancer | Index Medicus | Abridged Index Medicus
Journal Article
Pediatric neurology, ISSN 0887-8994, 2015, Volume 52, Issue 1, pp. 25 - 35
Pediatrics | Neurology | neurocognition | mental health | psycho-social | behavior | autism | neuropsychological | psychiatric disorders | learning disorders | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Tuberous Sclerosis - complications | Brain Diseases - diagnosis | Humans | Child, Preschool | Terminology as Topic | Infant | Mental Disorders - complications | Brain Diseases - physiopathology | Mental Disorders - physiopathology | Mental Disorders - psychology | Pilot Projects | Brain Diseases - complications | Tuberous Sclerosis - physiopathology | Adolescent | Checklist | Adult | Tuberous Sclerosis - diagnosis | Tuberous Sclerosis - psychology | Mental Disorders - diagnosis | Child | Brain Diseases - psychology | Tuberous sclerosis | Nervous system diseases | Neurosciences | Index Medicus
Journal Article
JAMA dermatology (Chicago, Ill.), ISSN 2168-6068, 01/2017, Volume 153, Issue 1, pp. 39 - 48
Life Sciences & Biomedicine | Dermatology | Science & Technology | Skin Neoplasms - drug therapy | Tuberous Sclerosis - complications | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Male | Patient Satisfaction | Young Adult | Angiofibroma - complications | Adult | Female | Child | Sirolimus - adverse effects | Facial Neoplasms - drug therapy | Double-Blind Method | Gels | Treatment Outcome | Sirolimus - blood | Antibiotics, Antineoplastic - administration & dosage | Skin Neoplasms - complications | Sirolimus - administration & dosage | Adolescent | Facial Neoplasms - complications | Administration, Topical | Angiofibroma - drug therapy
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2008, Volume 358, Issue 2, pp. 140 - 151
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Medical sciences | Tumors of the nervous system. Phacomatoses | Protein Kinases - metabolism | Tuberous Sclerosis - complications | Humans | Immunosuppressive Agents - therapeutic use | Lymphangioleiomyomatosis - physiopathology | Middle Aged | Liver Diseases - pathology | Lung Neoplasms - pathology | Male | Lung - diagnostic imaging | Lung Neoplasms - physiopathology | Angiomyolipoma - drug therapy | Lymphangioleiomyomatosis - pathology | Adult | Angiomyolipoma - etiology | Female | Sirolimus - adverse effects | Sirolimus - therapeutic use | Kidney Diseases - pathology | Angiomyolipoma - pathology | Lung - physiopathology | Lung Neoplasms - complications | Tuberous Sclerosis - genetics | Radiography | Magnetic Resonance Imaging | Lymphangioleiomyomatosis - complications | Protein Kinase Inhibitors - therapeutic use | Brain - pathology | Immunosuppressive Agents - adverse effects | TOR Serine-Threonine Kinases | Respiratory Function Tests | Drug therapy | Genetic aspects | Sclerosis | Proteins | Medical research | Mutation | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10056, pp. 2153 - 2163
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Tuberous Sclerosis - complications | Humans | Middle Aged | Seizures - drug therapy | Anticonvulsants - therapeutic use | Child, Preschool | Male | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Dose-Response Relationship, Drug | Adolescent | Everolimus - adverse effects | Adult | Everolimus - therapeutic use | Female | Aged | Child | Tuberous sclerosis | Nervous system diseases | Care and treatment | Seizures (Medicine) | Angiogenesis inhibitors | Epilepsy | Prescription drugs | Convulsions & seizures | Genetic disorders | Clinical trials | Mutation | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Developmental medicine and child neurology, ISSN 0012-1622, 06/2017, Volume 59, Issue 6, pp. 612 - 617
Pediatrics | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Learning Disorders - complications | Follow-Up Studies | Learning Disorders - mortality | Tuberous Sclerosis - complications | Humans | Middle Aged | Kidney Diseases - mortality | Male | United Kingdom | Epilepsy - mortality | Cause of Death | Epilepsy - complications | Young Adult | Adolescent | Aged, 80 and over | Adult | Female | Kidney Diseases - complications | Cohort Studies | Databases, Factual | Tuberous Sclerosis - mortality | Index Medicus
Journal Article